Brian Davis, M.A. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 16 Town Crier Dr, Suite 1, Brattleboro, VT 05301 Phone: 802-258-4629 |
Anthony S Parmenter, MA, LCMHC, AAP, NCC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1 Anna Marsh Ln., Brattleboro, VT 05301 Phone: 802-258-6718 |
Michael Burrows, N/A Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 16 Town Crier Dr, Brattleboro, VT 05301 Phone: 802-258-4623 |
Ms. Jean Zeeb, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 229 Western Ave, Brattleboro, VT 05301 Phone: 802-451-6204 |
Lisa C Mendelsund Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 54 Harris Pl, Brattleboro, VT 05301 Phone: 802-490-9644 |
Mary G. Coventry, MA LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview Street, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Ms. Imogen Holding, MA Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview St, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Mrs. Lydia M Barnes, MA LCMHC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 51 Fairview Street, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Ms. M Denise Wissell, M. ED Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 51 Fairview Street, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Philip Foldeak Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 229 Western Ave, Brattleboro, VT 05301 Phone: 802-257-9444 |
Mrs. Barbara Elizabeth Vitalis, MA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 39 Morningside Cmns, Brattleboro, VT 05301 Phone: 802-380-1243 |
Jaime Dawson, MA Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview Street, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Howard Frederic Bronson, MSJ, MCP. QMHP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 16 Town Crier Dr, Brattleboro, VT 05301 Phone: 802-258-4623 |
Sarah C Taylor, MA, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview St, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Michael Henry Earley, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 44 Fuller Dr, Brattleboro, VT 05301 Phone: 802-254-8294 |
Brian Condon Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 83 Oak St Apt 201, Brattleboro, VT 05301 Phone: 603-852-5348 |
Cynthia Stepler Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 16 Town Crier Dr, Brattleboro, VT 05301 Phone: 802-258-4623 |
Ms. Celia A Mackinnon, LMHC LMFT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 262 Western Ave, C/o Innerwell Integrative Counseling Services, Brattleboro, VT 05301 Phone: 802-231-2550 |
Mr. William Scott Gemmell, MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 193 Main St., Centre Congregational Church, Brattleboro, VT 05301 Phone: 802-275-2962 |
Rebecca I Davis, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 54 Harris Pl, Brattleboro, VT 05301 Phone: 802-258-0970 |
News Archive
Estrogen seems to act like a middleman in its positive effect on the brain, raising the possibility that future drugs may bypass the carcinogenic hormone altogether while reaping its benefits.
ArQule, Inc. today announced that the European Medicines Evaluation Agency (EMEA) has designated ARQ 197 as an orphan medical product for the treatment of soft tissue sarcoma.
Cancer Research UK welcomes the government's intention to ban the use of sunbeds by under-18s following the launch of a Private Member's Bill in Parliament by Julie Morgan, MP for Cardiff North.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
An international group led by Dr Banafshe Larijani, an Ikerbasque researcher seconded to the Biofisika Institute (UPV/EHU-University of the Basque Country, CSIC), has developed a new diagnostic method making it possible to accurately predict which cancer patients will respond positively to immunotherapy.
› Verified 8 days ago